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Human Subjects Protection and Inclusion of Women, Minorities, 
and Children 
Guidelines for Review of NIH Grant Applications 
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HUMAN SUBJECTS PROTECTION 
Requirements for Review 
  Federal regulations for the protection of human research  subjects (45 CFR 46), 
require that the evaluation of research applications that involve human subjects  take 
into consideration the risk to subjects, the adequacy of protections against risk, 
potential benefits of the research to subjects and others, and the importance of the 
knowledge to be gained 
  The NIH Peer Review regulations (42 C.F.R. 52h) specify that reviewers will take into 
account, in determining overall impact that the project in the application could have 
on the research field involved, the adequacy of the proposed protection for humans 
  Therefore, reviewers must evaluate the proposed plans to protect human subjects 
from research risks, as appropriate for the research proposed, as one of the review 
criteria that factor into the evaluation of scientific and technical merit 
  In addition to federal regulations about the protection of human research subjects, 
NIH policies require that applications involving Clinical Trials include a data and safety 
monitoring plan and that NIH-defined Phase III clinical trials also describe a data and 
safety monitoring board 
  Data safety and monitoring plans must also be evaluated by peer reviewers. 
 
Reviewer Responsibilities 
  For applications involving human subjects: 
  Determine if a claim for exemption is adequately justified in applications that indicate 
the proposed research is exempt  OR 
  Determine whether the involvement of human subjects in the proposed research is 
justified scientifically; evaluate the proposed plan for the involvement of human 
subjects in non-exempt human subjects research; and determine if subjects appear to  
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be adequately protected from research risks. 
  For applications that involve a clinical trial, determine if the plans for data and safety 
monitoring, including the description of a data and safety monitoring board if 
necessary, are adequate. 
  For applications that claim no involvement of human subjects but propose the use of 
existing human data or biological specimens, evaluate if the justification provided for not 
involving human subjects is acceptable. 
  Rate the application as Acceptable, Unacceptable, or Not Applicable in terms of human 
subjects involvement and prepare written comments, including specific comments 
describing concerns for applications rated as Unacceptable. 
  For applications that do not involve human subjects or the use of human data or 
specimens, rate the application as Not Applicable for this criterion.  In this case, the 
Inclusion criterion, as described below, will also be Not Applicable. 
 
Reviewer Comments 
Reviewer Comments are required for Protections for Human Subjects (unless Not Applicable).  
An example follows: 
  The applicant states that the proposed research involves minimal physical risk; 
however, genetics research is considered of moderate risk due to the possibility of 
breaches in confidentiality.  Insufficient detail is provided regarding measures to 
protect against such risk. 
 
 
INCLUSION OF WOMEN, MINORITIES, AND CHILDREN 
Requirements for Review 
  Public Law 103-43 requires that women and minorities be included in all clinical 
research studies, as appropriate for the scientific goals of the work proposed. 
  Additionally, NIH policy requires that women and members of minority groups and 
their subpopulations be included in Phase III clinical trials in numbers adequate to 
allow for valid analyses of sex/gender, racial, and/or ethnic differences in intervention 
effects 
  NIH policy also states that children (defined as persons under the age of 21) be 
included in human subjects research supported by NIH unless an acceptable 
justification for their exclusion is provided 
  The NIH Peer Review regulations (42 C.F.R. 52h) specify that reviewers will take into 
account, in determining overall impact that the project in the application could have 
on the research field involved, the adequacy of plans to include both genders, 
minorities, children and special populations as appropriate for the scientific goals of 
the research 
  Therefore, reviewers must evaluate the proposed plans for inclusion of women, 
minorities, and children as one of the review criteria that factor into the evaluation of 
scientific and technical merit. 
 
Reviewer Responsibilities 
  Evaluate whether the sex/gender, racial, and ethnic characteristics of the proposed 
sample and the plan for the inclusion of children are scientifically acceptable given the 
aims of the research.    
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  Rate the application as Acceptable or Unacceptable with respect to the proposed inclusion 
of Women, Minorities, and Children, assign codes, and include specific comments 
describing why the plans are acceptable or any concerns for applications rated as 
Unacceptable. 
Reviewer Coding 
Three digit alphanumeric codes are used to summarize reviewers’ evaluation of inclusion of 
women, minorities, and children.  The three digit code is comprised as follows. 
  First digit: G, M, or C to indicate gender, minority, or children, respectively 
  Second digit: A numerical code from 1-5 to identify what groups are included 
  Third digit: A or U to indicate scientific acceptability, given the stated research aims 
and the proposed inclusion plans  
Each application involving human subjects receives three separate alphanumeric codes, for 
sex/gender, minorities, and children, respectively. A code should be assigned to each 
individual project or subproject in an application containing multiple projects or subprojects 
and involving distinct populations or specimen collections.  A single overall code ALSO should 
be assigned to the entire application. If any project/subproject is found "Unacceptable" (U), 
the overall code should be U. The overall coding should reflect the acceptability of inclusion 
for all projects/subprojects even if the proposed inclusion plans vary for different studies. 
 
Sex/Gender Inclusion Codes 
  G1A = Both genders, acceptable 
  G1U = Both genders, unacceptable      
  G2A = Only women, acceptable 
  G2U = Only women, unacceptable 
  G3A = Only men, acceptable 
  G3U = Only men, unacceptable 
  G4A = gender composition unknown, acceptable 
  G4U = gender composition unknown, unacceptable 
 
Minority Inclusion Codes 
  M1A = Minority and nonminority, acceptable 
  M1U = Minority and nonminority, unacceptable 
  M2A = Only minority, acceptable 
  M2U = Only minority, unacceptable 
  M3A = Only nonminority, acceptable 
  M3U = Only nonminority, unacceptable 
  M4A = minority composition unknown, acceptable 
  M4U = minority composition unknown, unacceptable 
  M5A = only foreign subjects, acceptable 
  M5U = only foreign subjects, unacceptable 
 
Children Inclusion Codes 
  C1A = Children and adults, acceptable 
  C1U = Children and adults, unacceptable 
  C2A = Only children, acceptable 
  C2U = Only children, unacceptable 
  C3A = No children included, acceptable  
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  C3U = No children included, unacceptable 
  C4A = Representation of children unknown, acceptable 
  C4U = Representation of children unknown, unacceptable 
 
It is not expected that every study will include both sexes/genders, all minority groups and 
subgroups, and children.  Inclusion on the basis of sex/gender, race, and ethnicity, as well as 
the inclusion of children should be determined by the scientific aims of the study.  Applicants 
should describe and justify fully the distribution of individuals that will be included in the 
research. 
 
Reviewer Comments 
Reviewer comments are required for Inclusion of Women, Minorities, and Children 
regardless of acceptability rating, unless inclusion is Not Applicable.  Examples of 
comments follow. 
  (G1U) Gender representation is unacceptable.  Although both genders are represented, 
too few members of one gender are included to answer the questions posed. 
  (G2A) Gender composition is scientifically acceptable, although only females are 
represented, because the disease under study is not found in male subjects. 
  (G1A) Although there are relatively few females in the sample, the representation reflects 
the sex/gender ratio in the prevalence of the disorder; the plan is scientifically acceptable.  
  (C3A) No children included.  This is acceptable as knee replacement is rare in children as 
compared to adults. 
  (M4U) Minority representation is unknown.  The applicant does not provide sufficient 
information about the racial and ethnic composition of the study population.  The 
application does not comply with requirements and is unacceptable. 
 
BACKGROUND AND REFERENCES 
Human Subjects Protection 
Federal Regulations for Protection of Human Research Subjects (45 CFR 46): 
http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html 
 
More Information 
Peer Review Decision Trees for Human Subjects Protections and Inclusion Issues 
 
Definition of Human Subject 
A living individual about whom an investigator (whether professional or student) conducting 
research obtains 
1)  Data through intervention or interaction with the individual, or 
2)  Identifiable private information. 
  Intervention includes both physical procedures by which data are gathered (for 
example, venipuncture) and manipulations of the subject or the subject's environment 
that are performed for research purposes. Interaction includes communication or 
interpersonal contact between investigator and subject.  
  Private information includes information about behavior that occurs in a context in 
which an individual can reasonably expect that no observation or recording is taking 
place, and information which has been provided for specific purposes by an individual  
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and which the individual can reasonably expect will not be made public (for example, 
a medical record). Private information must be individually identifiable (i.e., the 
identity of the subject is or may readily be ascertained by the investigator or 
associated with the information) in order for obtaining the information to constitute 
research involving human subjects. 
 
Research Involving Coded Private Information or Biological Specimens 
Research that involves only the use of human specimens or data is not considered human 
subjects research if: 
  All subjects are deceased   OR 
  The data/specimens were not obtained specifically for the proposed research AND 
none of the investigators involved in the research can ascertain the identity of the 
subjects, either directly or indirectly. 
 
See http://www.hhs.gov/ohrp/policy/cdebiol.html for more detailed information 
 
Human Subjects Research Exemptions (45 CFR 46.101) 
1)  Research conducted in established or commonly accepted educational settings, 
involving normal educational practices, such as  
i.  research on regular and special education instructional strategies, or  
ii.  research on the effectiveness of or the comparison among instructional 
techniques, curricula, or classroom management methods. 
2)  Research involving the use of educational tests (cognitive, diagnostic, aptitude, 
achievement), survey procedures, interview procedures or observation of public 
behavior, unless: 
i.  information obtained is recorded in such a manner that human subjects can be 
identified, directly or through identifiers linked to the subjects; and  
ii.  any disclosure of the human subjects' responses outside the research could 
reasonably place the subjects at risk of criminal or civil liability or be damaging 
to the subjects' financial standing, employability, or reputation. 
3)  Research involving the use of educational tests (cognitive, diagnostic, aptitude, 
achievement), survey procedures, interview procedures, or observation of public 
behavior that is not exempt under paragraph (b)(2) of this section, if: 
i.  the human subjects are elected or appointed public officials or candidates for 
public office; or  
ii.  (ii) federal statute(s) require(s) without exception that the confidentiality of the 
personally identifiable information will be maintained throughout the research 
and thereafter. 
4)  Research involving the collection or study of existing data, documents, records, 
pathological specimens, or diagnostic specimens, if these sources are publicly 
available or if the information is recorded by the investigator in such a manner that 
subjects cannot be identified, directly or through identifiers linked to the subjects. 
5)  Research and demonstration projects which are conducted by or subject to the 
approval of department or agency heads, and which are designed to study, evaluate, 
or otherwise examine: 
i.  public benefit or service programs;  
ii.  procedures for obtaining benefits or services under those programs;  
iii.  possible changes in or alternatives to those programs or procedures; or 
iv.  possible changes in methods or levels of payment for benefits or services under 
those programs.  
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6)  Taste and food quality evaluation and consumer acceptance studies,  
i.  if wholesome foods without additives are consumed or  
ii.  if a food is consumed that contains a food ingredient at or below the level and 
for a use found to be safe, or agricultural chemical or environmental 
contaminant at or below the level found to be safe, by the Food and Drug 
Administration or approved by the Environmental Protection Agency or the 
Food Safety and Inspection Service of the U.S. Department of Agriculture. 
 
Data and Safety Monitoring Plan 
For information, visit Data and Safety Monitoring Plan.   
 
Inclusion of Women, Minorities, and Children 
NIH Policies Regarding Inclusion of Women and Minorities  
NIH Policies Regarding Inclusion of Children 
 
Definitions 
Clinical research:  
1)  Patient-oriented research. Research conducted with human subjects (or on material of 
human origin such as tissues, specimens and cognitive phenomena) for which an 
investigator (or colleague) directly interacts with human subjects. Excluded from this 
definition are in vitro studies that utilize human tissues that cannot be linked to a 
living individual. Patient-oriented research includes: (a) mechanisms of human 
disease, (b) therapeutic interventions, (c) clinical trials, or (d) development of new 
technologies.  
2)  Epidemiologic and behavioral studies.  
3)  Outcomes research and health services research.  
 
Note: Research that meets the criteria for Exemption 4 is not considered “clinical research” as defined by NIH. 
Therefore the NIH policies for inclusion of women, minorities, and children in clinical research, and planned 
enrollment reports do not apply to research projects covered by Exemption 4. 
Phase III clinical trials research: 
Phase III clinical trials research is defined as broadly based, prospective clinical 
investigations for the purpose of investigating the efficacy of the biomedical or behavioral 
intervention in large groups of human subjects (from several hundred to several 
thousand) by comparing the intervention to other standard or experimental interventions 
as well as to monitor adverse effects, and to collect information that will allow the 
intervention to be used safely. 
Sex/Gender: For the purposes of reporting inclusion data, individuals are classified as either 
female or male.  Sex/gender classification is based on self-report by participants enrolled in 
the research study.  NIH policy does not require that inclusion data be based on sex assigned 
at birth.  Reviewers should be aware that the proposed research may include individuals 
whose gender identity differs from their sex assigned at birth   
 
Minority group: A readily identifiable subset of the U.S. population distinguished by either  
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racial, ethnic, and/or cultural heritage.  In accordance with OMB Directive No. 15, the 
currently defined racial groups are American Indian/Alaskan Native; Asian; Native Hawaiian 
or Other Pacific Islander; Black or African American; White. Currently defined ethnic groups 
are Hispanic or Latino; Not Hispanic or Latino.  It is expected that study participants will be 
asked to identify their ethnicity and their race(s).   
Children: Individuals under the age of 21 years. 
 
 
 